About: Bolt Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company offers product candidates and platform technologies, including PRA-216, BDC-4182, a Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; the Boltbody Immune-Stimulating Antibody Conjugate (ISAC) platform, and the INSPIRE platform. It serves patients, clinical investigators, and biopharmaceutical partners. The company is based in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.36 (-3.34%)
BOLT NASDAQ Bolt Biotherapeutics
Bolt Biotherapeutics share price
Atividade de preço de BOLT
Último preço
$ 6,360
Variação (24h)
-0,22 USD (3,34%)
Volume
75.19K
Volume (média 4 sem.)
-
Abertura
$ 6,47
Variação do dia
$ 6,30 - $ 6,61
Fechamento anterior
$ 6,58
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
BOLT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals